相似文献
1
Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts.
Antimicrob Agents Chemother. 1982 Feb;21(2):355-7. doi: 10.1128/AAC.21.2.355.
2
Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
Antimicrob Agents Chemother. 1982 Nov;22(5):763-70. doi: 10.1128/AAC.22.5.763.
3
[Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
Ann Biol Clin (Paris). 1989;47(9):546-9.
4
[Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
Mykosen. 1981 May;24(5):261-74.
5
[Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].
Pathol Biol (Paris). 1986 May;34(5):536-9.
6
Combined action of amphotericin B and 5-fluorocytosine on pathogenic yeasts susceptible to either drug alone.
Chemotherapy. 1981;27(4):247-51. doi: 10.1159/000237987.
7
Determination of serum 5-fluorocytosine concentrations in the presence of ketoconazole.
J Antimicrob Chemother. 1983 Aug;12(2):189-92. doi: 10.1093/jac/12.2.189.
8
Influence of pH on ketoconazole activity against Candida parapsilosis and Candida albicans.
Res Commun Chem Pathol Pharmacol. 1982 Sep;37(3):495-8.
9
In vitro activity of antifungal agents against yeast species.
Chemotherapy. 1983;29(2):104-10. doi: 10.1159/000238182.
10
In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
J Clin Microbiol. 1984 Mar;19(3):412-6. doi: 10.1128/jcm.19.3.412-416.1984.
引用本文的文献
1
Combination antifungal therapy.
Antimicrob Agents Chemother. 2004 Mar;48(3):693-715. doi: 10.1128/AAC.48.3.693-715.2004.
2
Novel synergism of two antifungal agents, copiamycin and imidazole.
Antimicrob Agents Chemother. 1983 Oct;24(4):552-9. doi: 10.1128/AAC.24.4.552.
本文引用的文献
1
Treatment of coccidioidomycosis with ketoconazole: clinical and laboratory studies of 18 patients.
Rev Infect Dis. 1980 Jul-Aug;2(4):661-73. doi: 10.1093/clinids/2.4.661.
2
Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole.
Rev Infect Dis. 1980 Jul-Aug;2(4):551-58. doi: 10.1093/clinids/2.4.551.
3
In vitro studies with 5-fluorocytosine.
Appl Microbiol. 1969 Jun;17(6):871-7. doi: 10.1128/am.17.6.871-877.1969.
4
Inhibition of potentially pathogenic yeastlike fungi by clotrimazole in combination with 5-fluorocytosine or amphotericin B.
Antimicrob Agents Chemother. 1976 Jun;9(6):863-5. doi: 10.1128/AAC.9.6.863.
5
In vitro synergy and antagonism of antifungal agents against yeast-like fungi.
Postgrad Med J. 1979 Sep;55(647):683-6. doi: 10.1136/pgmj.55.647.683.
6
Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent.
J Med Chem. 1979 Aug;22(8):1003-5. doi: 10.1021/jm00194a023.
7
Ketoconazole -- a new broad spectrum orally active antimycotic.
Experientia. 1979 May 15;35(5):606-7. doi: 10.1007/BF01960348.
8
Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy.
Ann Intern Med. 1978 Jul;89(1):91-106. doi: 10.7326/0003-4819-89-1-91.
9
Flucytosine.
Ann Intern Med. 1977 Mar;86(3):319-21. doi: 10.7326/0003-4819-86-3-319.
Zotero 插件